A Nationwide, Population-Based Epidemiology Study of Primary Central Nervous System Tumors in Korea, 2007-2016: A Comparison with United States Data

Kang, Hee Yoon; Song, Sang Woo; Ha, Johyun; Won, Young Joo; Park, Shin Young; Yoo, Heon; Jung, Kyu Won

doi:10.4143/crt.2020.847

Cited by 24 publications

(31 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Further studies in White populations also support a male prepondance 1 , 19 , 32 , 35 – 37 , 45 . In the Korean population, the IRRs (male-female ratio) were 1.31, 1.32, 1.27, 1.36 18 , 31 , 41 , 46 . Four studies based on Chinese have reported IRRs of 1.57, 1.69, 1.43, and 1.34 ( Figure 2B ) 19 , 38 , 39 , 47 .…”

Section: Epidemiology Characterizationmentioning

confidence: 99%

“…In Japan, the ASR was 1.26 in Miyazaki prefecture 30 . Four Korean studies reported ASR values of 0.59, 0.77, 0.87, and 1.11 ( Figure 2A ) 18 , 31 , 41 , 42 . Lower ASR in East Asians was still observed when only older adults (≥40 years of age) were considered 18 .…”

Section: Epidemiology Characterizationmentioning

confidence: 99%

“…Four Korean studies reported ASR values of 0.59, 0.77, 0.87, and 1.11 ( Figure 2A ) 18 , 31 , 41 , 42 . Lower ASR in East Asians was still observed when only older adults (≥40 years of age) were considered 18 . In addition, all East Asian cohorts presented a lower ASR than the USA API group.…”

Section: Epidemiology Characterizationmentioning

confidence: 99%

See 2 more Smart Citations

Epidemiological characteristics and genetic alterations in adult diffuse glioma in East Asian populations

Xin

Chai

et al. 2022

Cancer Biol Med

View full text Add to dashboard Cite

Understanding the racial specificities of diseases—such as adult diffuse glioma, the most common primary malignant tumor of the central nervous system—is a critical step toward precision medicine. Here, we comprehensively review studies of gliomas in East Asian populations and other ancestry groups to clarify the racial differences in terms of epidemiology and genomic characteristics. Overall, we observed a lower glioma incidence in East Asians than in Whites; notably, patients with glioblastoma had significantly younger ages of onset and longer overall survival than the Whites. Multiple genome-wide association studies of various cohorts have revealed single nucleotide polymorphisms associated with overall and subtype-specific glioma susceptibility. Notably, only 3 risk loci—5p15.33, 11q23.3, and 20q13.33—were shared between patients with East Asian and White ancestry, whereas other loci predominated only in particular populations. For instance, risk loci 12p11.23, 15q15-21.1, and 19p13.12 were reported in East Asians, whereas risk loci 8q24.21, 1p31.3, and 1q32.1 were reported in studies in White patients. Although the somatic mutational profiles of gliomas between East Asians and non-East Asians were broadly consistent, a lower incidence of EGFR amplification in glioblastoma and a higher incidence of 1p19q-IDH-TERT triple-negative low-grade glioma were observed in East Asian cohorts. By summarizing large-scale disease surveillance, germline, and somatic genomic studies, this review reveals the unique characteristics of adult diffuse glioma among East Asians, to guide clinical management and policy design focused on patients with East Asian ancestry.

show abstract

Section: Epidemiology Characterizationmentioning

confidence: 99%

Section: Epidemiology Characterizationmentioning

confidence: 99%

See 1 more Smart Citation

Epidemiological characteristics and genetic alterations in adult diffuse glioma in East Asian populations

Xin

Chai

et al. 2022

Cancer Biol Med

View full text Add to dashboard Cite

show abstract

“…In Mongolia the most common location of CNS tumours was the brain regardless of sex and age. In contrast, the meninges were the most common location in other large registries such as Korea and the United States of America (US) [17,18]. However, those registries collect data on non-malignant tumours and the meningeal tumours were most likely non-malignant.…”

Section: Discussionmentioning

confidence: 99%

The epidemiology series of brain-related disorders in Mongolia: nationwide registry-based epidemiological study on CNS tumours in Mongolia, 2015–2019

Sandagdorj¹,

Tudev²,

Jamiyandorj³

et al. 2022

J. Integr. Neurosci.

View full text Add to dashboard Cite

No epidemiological study on central nervous system tumours is available for Mongolia. The aim of this study was to determine the incidence, mortality and survival of people diagnosed with central nervous system tumours in Mongolia. It reports cancer data for the entire population (3.3 million) during the period between 2015 and 2019. Data was obtained from the National Cancer Registry of Mongolia. Diagnosis of tumours was established according to the diagnostic criteria of the International Classification of Diseases-10 (ICD-10). Incidence and mortality rates were calculated as mean annual numbers per 100,000 population. Age-standardized incidence and age-standardized mortality rates were calculated from age-specific rates by weighting directly from the World Standard Population. The three-year survival from 2015 through 2017 was calculated between treatment types by the Kaplan-Meier survival analysis. It found 515 (adults: 83 %; children: 17%) newly diagnosed central nervous system tumour cases over the five year period. The national agestandardized incidence of central nervous system tumours for the entire population was 3.7 per 100,000. The rate was higher for males than females (4.2 versus 3.4 per 100,000, respectively). Only 23% of the diagnosed cases were confirmed histologically. The most common tumour was glioma (57.6% of histologically verified tumours). In children (age 0--19 years) the age-specified incidence rate of tumours was 1.4 per 100,000. Geographically, the age-standardized incidences of the Eastern region were higher than the country average rates for both genders. During the period, 381 deaths were registered with an age-standardized mortality rate of 3.0 per 100,000 population. Furthermore, the overall three-year survival rate was 40.6% (out of 283 patients, 115 survived). The five-year prevalence of tumours was 183 and the mean per 100,000 population was 5.5. In conclusion, the data from the National Cancer Registry indicate that the incidence and survival rates of central nervous system tumours in Mongolia are relatively low. The most common location of central nervous system tumours was the brain. Glioma was the most common tumour among histologically confirmed cases. Despite the limitations, data from this study should provide information for national health policy and health care assessment. To improve the diagnosis, prognosis and treatment of central nervous system tumours, expansion of the cancer registry through collecting data on non-malignant tumours, increasing the rate of histological verification, conducting studies on cancer epidemiology and the introduction of advanced treatment technologies for central nervous system tumours are recommended.

show abstract

“…Approximately 308,102 new cases and 251,329 brain and CNS tumor deaths were diagnosed globally in 2020 (2). The incidence of brain and central nervous system tumors has increased in several regions since the standardization of tumor registration and the improvement of diagnostic techniques (4,7,8).…”

Section: Introductionmentioning

confidence: 99%

The comparative burden of brain and central nervous system cancers from 1990 to 2019 between China and the United States and predicting the future burden

Huang

Yan

et al. 2022

Front. Public Health

View full text Add to dashboard Cite

BackgroundBrain and central nervous system (CNS) cancers represent a major source of cancer burden in China and the United States. Comparing the two countries' epidemiological features for brain and CNS cancers can help plan interventions and draw lessons.MethodsData were extracted from the Global Burden of Disease repository. The average annual percentage change (AAPC) and relative risks of cancer burdens were calculated using joinpoint regression analysis and age-period-cohort (APC) models, respectively. Moreover, a Bayesian APC model was employed to predict the disease burden over the next decade.ResultsFrom 1990 to 2019, the number of incidences, deaths, and disability-adjusted life-years (DALYs) increased in China and the US, with a larger increase in China. Age-standardized incidence rates in China and the United States have shown an increasing trend over the past three decades, with AAPCs of 0.84 and 0.16%, respectively. However, the rates of age-standardized mortality and age-standardized DALYs decreased in both countries, with a greater decrease in China. Overall, age trends in cancer burden were similar for males and females, with two peaks in the childhood and elderly groups, respectively. The period and cohort effects on incidence showed an overall increasing trend in China and limited change in the US. However, the period effects for mortality and DALY were decreasing in both countries, while the cohort effects tended to increase and then decrease. Moreover, we predicted that the cancer burdens would continue to rise in China over the next decade.ConclusionThe burden of brain and CNS cancers is substantial and will continue to increase in China. Comprehensive policy and control measures need to be implemented to reduce the burden.

show abstract

A Nationwide, Population-Based Epidemiology Study of Primary Central Nervous System Tumors in Korea, 2007-2016: A Comparison with United States Data

Cited by 24 publications

References 25 publications

Epidemiological characteristics and genetic alterations in adult diffuse glioma in East Asian populations

Epidemiological characteristics and genetic alterations in adult diffuse glioma in East Asian populations

The epidemiology series of brain-related disorders in Mongolia: nationwide registry-based epidemiological study on CNS tumours in Mongolia, 2015–2019

The comparative burden of brain and central nervous system cancers from 1990 to 2019 between China and the United States and predicting the future burden

Contact Info

Product

Resources

About